Retisert (Fluocinolone Acetonide Intravitreal) - Summary

RETISERT SUMMARY

RETISERT®
(fluocinolone acetonide intravitreal implant) 0.59 mg

RETISERT® (fluocinolone acetonide intravitreal implant) 0.59 mg is a sterile implant designed to release fluocinolone acetonide locally to the posterior segment of the eye at a nominal initial rate of 0.6µg/day, decreasing over the first month to a steady state between 0.3-0.4 µg/day over approximately 30 months.

RETISERT is indicated for the treatment of chronic non-infectious uveitis affecting the posterior segment of the eye.

See all Retisert indications & dosage >>

RETISERT NEWS HIGHLIGHTS

Media Articles Related to Retisert (Fluocinolone Intravitreal)

Melatonin May Save Eyesight In Inflammatory Disease
Source: Eye Health / Blindness News From Medical News Today [2008.11.24]

more >>

Published Studies Related to Retisert (Fluocinolone Intravitreal)

Fluocinolone acetonide implant (Retisert) for noninfectious posterior uveitis: thirty-four-week results of a multicenter randomized clinical study. [2006.06]

Long-term follow-up results of a pilot trial of a fluocinolone acetonide implant to treat posterior uveitis. [2005.07]

Fluocinolone acetonide sustained drug delivery device for chronic central retinal vein occlusion: 12-month results. [2008.08]

Intraocular pressure in patients with uveitis treated with fluocinolone acetonide implants. [2007.11]

Intraocular Pressure in Patients With Uveitis Treated With Fluocinolone Acetonide Implants. [2007.10.08]

more >>

Clinical Trials Related to Retisert (Fluocinolone Intravitreal)

Fluocinolone Acetonide Implant for Retinal Vein Occlusion (RVO) [Recruiting]

Efficacy of Fluocinolone Acetonide Intravitreal Implant in Diabetic Macular Edema [Completed]

Fluocinolone Implant to Treat Macular Degeneration [Completed]

Re-Implantation of a Fluocinolone Acetonide Implant for Non-Infectious Uveitis Affecting the Posterior Segment [Recruiting]

Safety and Efficacy of Fluocinolone Acetonide Intravitreal Implant [Terminated]

more >>